Epidemiology of kidney stones in the European union

Urolithiasis: Basic Science and Clinical Practice

Volumn , Issue , 2012, Pages 3-12

  Osther, Palle J S ^a  

^a EAU Section of Urolithiasis (EULIS)   (Denmark)

Author keywords

Age related stone formation; Calcium oxalate stones; Calcium phosphate stones; Cystine stones; Geographical variation; Incidence; Infection stones; Oxalates; Pediatric stones; Practice patterns; Prevalence; Recurrence; Staghorn stones; Stone composition; Stone site; Urates; Uric acid stones; Urinary stones; Urine composition

Indexed keywords

EID: 84922172675     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-4387-1_1     Document Type: Chapter

References (36)

1. Hughes P. Kidney stones epidemiology. Nephrology. 2007;12:26-30.
2. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287-93.
3. European Commission Eurostat Yearbook2011. http://epp.eurostat. ec.europa.eu/portal/page/portal/eurostat/home/. Accessed on Dec 7, 2012.
4. Rousad A, Pedrajas A. Estudiio epidemiolócico de la urolithiasis en Espana. Asociación Espanola de Urología. Grupo de Urolithiasis; 1986.
5. Sánchez-Martin FM, Millán Rodríguez F, Esquena Fernández S, Segarra Tomás J, Rousaud Barón F, Martínez-Rodríguez F, et al. Incidencia y prevalencia de la urolithiasis en Espana: revision de los datos originales disponibles hasta la actualidad. Actas Urol Esp. 2007;31:511-20.
6. Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E. Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol. 2000;37:23-5.
7. Hesse A, Brandle E, Wilbert D, Kohrmann K-U, Alken P. Study on the prevalence and incidence of Urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003;44:709-13.
8. Vahlensieck EW, Bach D, Hesse A. Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res. 1982;10:161-4.
9. Hesse A, Siener R. Current aspects of epidemiology and nutrition in urinary stones. World J Urol. 1997;15:165-71.
10. Knoll T. Epidemiology, pathogenesis and pathophysiology of urolithiasis. Eur Urol Suppl. 2010;9:802-6.
11. Knoll T, Schubert AB, Fahlenkamp DF, Leusmann DB, Wendt- Nordahl G, Schubert G. Urolithiasis through the ages: data on more than 200,000 urinary stone analysis. J Urol. 2011;185:1304-11.
12. Daudon M, Doré J-C, Jubgers P, Lacour B. Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach. Urol Res. 2004;32:241-7.
13. Galán JA, Conte A, Llobera A, Costa-Bauzá A, Grases F. A comparative study between etiological factors of calcium oxalate monohydrate and calcium oxalate dihydrate urolithiasis. Urol Int. 1996;56:79-85.
14. Trinchieri A, Castelnuovo C, Lizzano R, Zanetti G. Calcium stone disease: a multiform reality. Urol Res. 2005;33:194-8.
15. Andreassen K, Poulsen AL, Olsen PR, Aabeck J, Osther PJ. Classification of urolithiasis in Denmark: A national survey. European Urology Meeting 2007;2(1):126.
16. Maurice-Estepa L, Levillian P, Lacour B, Daudon M. Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. Scand J Urol Nephrol. 1999;33:299-302.
17. Daudon M, Labrunie M, Hennequin C, Lacour B, Jungers P. Relative influence of calcium and oxalate urine concentration on the risk of calcium oxalate crystallization. In: Jungers P, Daudon M, editors. Renal stone disease. Crystallization process, pathophysiology, metabolic disorders and prevention. Paris: Elsevier; 1997. p. 72.
18. Azadbakht L, Ezmaillzadeh A. Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women. J Nutr. 2009;139:335-9.
19. Traxer O, Lechevallier E, Saussine C, Daudon M, Haymann, JP. Metabolic syndrome and urolithiasis. A new concept for the urologist. Prog Urol. 2008;18:828-31.
20. Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after the first renal stone episode. Urol Res. 1990;18:397-9.
21. Siener R, Glatz S, Nicolay C, Hesse A. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol. 2003;44:467-74.
22. Osther PJ, Grenabo L, Haraldsson G, Holmberg G, Lindell O, Mogensen P, et al. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones. Scand J Urol Nephrol. 1999;33:372-81.
23. Tiselius H-G. Epidemiology and medical management of stone disease. BJU Int. 2003;91:758-67.
24. Trinchieri A, Dormia G, Montanan Z, Zanetti G. Cystinuria: definition, epidemiology and clinical aspects. Arch Ital Urol Androl. 2004;76(3): 129-34.
25. Abate N, Chandalia M, Cabo-Chan AV, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004; 65:386-92.
26. Cabello-Tomas ML, Garcia-Gomez AM, Guillen-Domiguez ML. Pilot screening programme for cystinuria in the Valencian Community. Eur J Epidemiol. 1999;15:681-4.
27. Schmidt C, Vester U, Hesse A, Lahme S, Lang F, Zerres K, Eggermann T, and Members of the Arbeitsgemeinschaft Pädiatrische Nephrologie. The population-specific distribution and frequencies of genomic variants in the SLC3A1 and SLC7A9 genes and their application in molecular genetic testing of cystinuria. Urol Res. 2004;32:75-8.
28. Gambaro G, Feltrin GP, Lupo A, Bonfante L, D’Angelo A, Antonello A. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. Kidney Int. 2006;69:663-70.
29. Laube M, Hess B, Terrier F, Vock P, Jaeger P. Prevalence of medullary sponge kidney in patients with and without nephrolithiasis. Praxis. 1995;84:1224-30.
30. Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg P. Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism. Urol Res. 1993;2:169-73.
31. Trinchieri A, Rovera F, Nespoli R. Clinical observations on 2086 patients with upper urinary tract stones. Arch Ital Urol Androl. 1996;68:251-8.
32. Evan AP, Lingeman JE, Coe FL, Worcester EM. Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003;111:607-16.
33. Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004; 171:1920-4.
34. Tiselius HG. A hypothesis of calcium stone formation: an interpretation of stone research during the past decades. Urol Res. 2011; 39:231-43. Epub 2011 Jan 19.
35. D’Armiento M, Autorino R, De Sio M. PCNL in Italy. Arch Ital Urol Androl. 2010;82:26-9.
36. Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005; 173:1601-5.